NEW YORK, July 13, 2011: Today, Kinetic Concepts, Inc. (KCI), a wound-care company, announced that it has entered into a definitive merger agreement under which a consortium comprised of private equity funds led by Apax Partners, will acquire KCI for $68.50 per share in cash. The transaction is valued at $6.3 billion.
Morgan Lewis advised KCI on regulatory matters and on Japanese legal issues central to the transaction. The team consisted of FDA and Healthcare partners Elizabeth Bierman and Phoebe Mounts, who advised on U.S. FDA regulatory work, as well as FDA and Healthcare partner Stephen Mahinka, Business and Finance partner Gregory Salathé and Satoru Nagasaka of TMI Associates (with whom Morgan Lewis has a joint venture), who advised on the Japanese issues.
For more information about the transaction, please see KCI's press release.